Latest Insider Transactions at Azenta, Inc. (AZTA)
This section provides a real-time view of insider transactions for Azenta, Inc. (AZTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Azenta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Azenta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 09
2024
|
John Marotta President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,273
+50.0%
|
$150,558
$46.15 P/Share
|
Aug 09
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+24.67%
|
$348,315
$55.27 P/Share
|
Aug 09
2024
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
10,856
+9.81%
|
$597,080
$55.27 P/Share
|
Aug 09
2024
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+39.9%
|
$348,315
$55.27 P/Share
|
Aug 09
2024
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+28.6%
|
$348,315
$55.27 P/Share
|
Aug 09
2024
|
Herman Cueto EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,309
+30.15%
|
$621,995
$55.27 P/Share
|
Aug 01
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,000
-1.11%
|
$62,000
$62.05 P/Share
|
Jul 25
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,000
-3.23%
|
$180,000
$60.0 P/Share
|
May 20
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
584
-15.59%
|
$29,784
$51.36 P/Share
|
Apr 01
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,000
-1.06%
|
$60,000
$60.15 P/Share
|
Mar 08
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-4.08%
|
$268,000
$67.5 P/Share
|
Mar 07
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,000
-2.88%
|
$585,000
$65.14 P/Share
|
Feb 12
2024
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
3,603
+27.73%
|
$234,195
$65.93 P/Share
|
Feb 12
2024
|
Tina Susan Nova |
SELL
Grant, award, or other acquisition
|
Direct |
2,465
-28.88%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Didier Hirsch |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+50.0%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Edward Peter Bousa |
SELL
Grant, award, or other acquisition
|
Direct |
2,465
-50.0%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+16.13%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+50.0%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Michael Rosenblatt |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+15.9%
|
$160,225
$65.93 P/Share
|
Feb 12
2024
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
2,465
+7.69%
|
$160,225
$65.93 P/Share
|
Feb 01
2024
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
324
+1.03%
|
$12,636
$39.41 P/Share
|
Feb 01
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
448
+3.35%
|
$17,472
$39.41 P/Share
|
Jan 31
2024
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
151
+0.48%
|
$8,003
$53.01 P/Share
|
Jan 31
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
64
+0.49%
|
$3,392
$53.01 P/Share
|
Jan 31
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Grant, award, or other acquisition
|
Direct |
311
-7.67%
|
$20,215
$65.2 P/Share
|
Dec 05
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,175
-16.71%
|
$289,800
$56.6 P/Share
|
Dec 01
2023
|
David Dong Wang SVP & GM, SMS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138
-1.44%
|
$7,866
$57.96 P/Share
|
Nov 17
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,179
-6.47%
|
$279,666
$54.83 P/Share
|
Nov 16
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,779
-2.24%
|
$147,287
$53.81 P/Share
|
Nov 16
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,448
+4.79%
|
$1,212,192
$54.57 P/Share
|
Nov 16
2023
|
Stephen S Schwartz CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,865
-2.94%
|
$681,845
$53.81 P/Share
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,582
+12.89%
|
$247,428
$54.57 P/Share
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,946
-10.05%
|
$156,138
$53.81 P/Share
|
Nov 16
2023
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+25.01%
|
$173,178
$54.57 P/Share
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+20.43%
|
$173,178
$54.57 P/Share
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Sale (or disposition) back to the issuer
|
Direct |
458
-4.7%
|
$24,274
$53.81 P/Share
|
Nov 16
2023
|
Herman Cueto EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,890
+44.05%
|
$804,060
$54.57 P/Share
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,291
+2.78%
|
$123,714
$54.57 P/Share
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,161
-2.7%
|
$114,533
$53.81 P/Share
|
Nov 16
2023
|
Violetta Hughes VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,374
+25.3%
|
$74,196
$54.57 P/Share
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
5,498
+4.89%
|
$296,892
$54.57 P/Share
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,831
-1.77%
|
$97,043
$53.81 P/Share
|
Nov 16
2023
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+50.0%
|
$173,178
$54.57 P/Share
|
Nov 15
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,297
+4.84%
|
$340,038
$54.13 P/Share
|
Nov 15
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,426
+3.62%
|
$887,004
$54.13 P/Share
|
Nov 15
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,107
+12.28%
|
$221,778
$54.13 P/Share
|
Nov 15
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
877
+8.26%
|
$47,358
$54.13 P/Share
|
Nov 15
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+3.47%
|
$155,250
$54.13 P/Share
|
Nov 15
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,559
+3.33%
|
$192,186
$54.13 P/Share
|
Aug 11
2023
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
10,877
-12.37%
|
$609,112
$56.03 P/Share
|